Persistent Asset Partners’s Elevation Oncology ELEV Stock Holding History

Persistent Asset Partners’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-83,416	Closed	-$30.6K	–	262
2025 Q2	$30.6K	Buy	+83,416	New	+$27.8K	0.02%	156

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Persistent Asset Partners's ELEV Position: Q3 2025 in Review

Persistent Asset Partners sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 83,416 shares — an estimated $30.6K sold.

Persistent Asset Partners first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $30.6K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Persistent Asset Partners reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Persistent Asset Partners sold 83,416 Elevation Oncology shares in Q3 2025, an estimated $30.6K.
Persistent Asset Partners first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Persistent Asset Partners's Elevation Oncology position peaked at $30.6K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.